The Next-Gen Oncology track explores breakthrough innovations that are redefining the future of cancer research, diagnosis, and treatment. This track highlights cutting-edge advancements in precision oncology, immunotherapy, targeted molecular therapies, and gene-editing technologies that are transforming patient outcomes. Sessions will examine the integration of multi-omics profiling, liquid biopsies, and AI-driven tumor analytics to enable earlier detection, real-time disease monitoring, and highly personalized treatment strategies. Emphasis will be placed on overcoming drug resistance, optimizing combination therapies, and accelerating translational research from laboratory discovery to clinical application.